Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 5
2000 6
2001 15
2002 32
2003 64
2004 60
2005 82
2006 97
2007 117
2008 140
2009 155
2010 188
2011 191
2012 186
2013 262
2014 236
2015 252
2016 296
2017 289
2018 270
2019 252
2020 209
2021 28
Text availability
Article attribute
Article type
Publication date

Search Results

2,960 results
Results by year
Filters applied: . Clear all
Page 1
Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease.
Kolkailah AA, Alreshq RS, Muhammed AM, Zahran ME, Anas El-Wegoud M, Nabhan AF. Kolkailah AA, et al. Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD012318. doi: 10.1002/14651858.CD012318.pub2. Cochrane Database Syst Rev. 2018. PMID: 29665617 Free PMC article. Review.
The mainstay of management of CAD is medical therapy and revascularisation. Revascularisation can be achieved via coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI). ...OBJECTIVES: To assess the bene …
The mainstay of management of CAD is medical therapy and revascularisation. Revascularisation can be achieved via coronary
Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores.
Ueki Y, Bär S, Losdat S, Otsuka T, Zanchin C, Zanchin T, Gragnano F, Gargiulo G, Siontis GCM, Praz F, Lanz J, Hunziker L, Stortecky S, Pilgrim T, Heg D, Valgimigli M, Windecker S, Räber L. Ueki Y, et al. EuroIntervention. 2020 Aug 28;16(5):371-379. doi: 10.4244/EIJ-D-20-00052. EuroIntervention. 2020. PMID: 32065586 Free article.
AIMS: The Academic Research Consortium for High Bleeding Risk (ARC-HBR) defined consensus-based criteria for patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI). We aimed to validate the ARC-HBR criteria for the ble …
AIMS: The Academic Research Consortium for High Bleeding Risk (ARC-HBR) defined consensus-based criteria for patients at high bleeding risk …
Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.
Gershlick AH, Khan JN, Kelly DJ, Greenwood JP, Sasikaran T, Curzen N, Blackman DJ, Dalby M, Fairbrother KL, Banya W, Wang D, Flather M, Hetherington SL, Kelion AD, Talwar S, Gunning M, Hall R, Swanton H, McCann GP. Gershlick AH, et al. J Am Coll Cardiol. 2015 Mar 17;65(10):963-72. doi: 10.1016/j.jacc.2014.12.038. J Am Coll Cardiol. 2015. PMID: 25766941 Free PMC article. Clinical Trial.
BACKGROUND: The optimal management of patients found to have multivessel disease while undergoing primary percutaneous coronary intervention (P-PCI) for ST-segment elevation myocardial infarction is uncertain. ...Complete revascularization was p …
BACKGROUND: The optimal management of patients found to have multivessel disease while undergoing primary percutaneous coronary
Revascularization for Coronary Artery Disease: Principle and Challenges.
Gu D, Qu J, Zhang H, Zheng Z. Gu D, et al. Adv Exp Med Biol. 2020;1177:75-100. doi: 10.1007/978-981-15-2517-9_3. Adv Exp Med Biol. 2020. PMID: 32246444 Review.
Coronary revascularization is the most important strategy for coronary artery disease. ...The development of fibrinolytic agents has improved the outcomes of ST-elevation myocardial infarction. Percutaneous coronary intervention has becom
Coronary revascularization is the most important strategy for coronary artery disease. ...The development of fibrinolyt
Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.
Holm NR, Mäkikallio T, Lindsay MM, Spence MS, Erglis A, Menown IBA, Trovik T, Kellerth T, Kalinauskas G, Mogensen LJH, Nielsen PH, Niemelä M, Lassen JF, Oldroyd K, Berg G, Stradins P, Walsh SJ, Graham ANJ, Endresen PC, Fröbert O, Trivedi U, Anttila V, Hildick-Smith D, Thuesen L, Christiansen EH; NOBLE investigators. Holm NR, et al. Lancet. 2020 Jan 18;395(10219):191-199. doi: 10.1016/S0140-6736(19)32972-1. Epub 2019 Dec 23. Lancet. 2020. PMID: 31879028 Clinical Trial.
BACKGROUND: Percutaneous coronary intervention (PCI) is increasingly used in revascularisation of patients with left main coronary artery disease in place of the standard treatment, coronary artery bypass grafting (CABG). ...INTERP …
BACKGROUND: Percutaneous coronary intervention (PCI) is increasingly used in revascularisation of patient …
Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
Chacko L, P Howard J, Rajkumar C, Nowbar AN, Kane C, Mahdi D, Foley M, Shun-Shin M, Cole G, Sen S, Al-Lamee R, Francis DP, Ahmad Y. Chacko L, et al. Circ Cardiovasc Qual Outcomes. 2020 Feb;13(2):e006363. doi: 10.1161/CIRCOUTCOMES.119.006363. Epub 2020 Feb 17. Circ Cardiovasc Qual Outcomes. 2020. PMID: 32063040 Free PMC article.
BACKGROUND: In patients presenting with ST-segment-elevation myocardial infarction, percutaneous coronary intervention (PCI) reduces mortality when compared with fibrinolysis. In other forms of coronary artery disease (CAD), however, it has been …
BACKGROUND: In patients presenting with ST-segment-elevation myocardial infarction, percutaneous coronary intervention
Percutaneous coronary intervention of bifurcation lesions and platelet reactivity.
Redfors B, Généreux P, Witzenbichler B, Kirtane AJ, Maehara A, Weisz G, Madhavan MV, McAndrew T, Mehran R, Stone GW. Redfors B, et al. Int J Cardiol. 2018 Jan 1;250:92-97. doi: 10.1016/j.ijcard.2017.10.022. Epub 2017 Oct 7. Int J Cardiol. 2018. PMID: 29074039
BACKGROUND: Although bifurcation percutaneous coronary intervention (PCI) is associated with lower procedural success rates and higher risk of complications, there are little data regarding outcomes after successful bifurcation PCI with contempo …
BACKGROUND: Although bifurcation percutaneous coronary intervention (PCI) is associated with lower procedural su …
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
Mäkikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IB, Trovik T, Eskola M, Romppanen H, Kellerth T, Ravkilde J, Jensen LO, Kalinauskas G, Linder RB, Pentikainen M, Hervold A, Banning A, Zaman A, Cotton J, Eriksen E, Margus S, Sørensen HT, Nielsen PH, Niemelä M, Kervinen K, Lassen JF, Maeng M, Oldroyd K, Berg G, Walsh SJ, Hanratty CG, Kumsars I, Stradins P, Steigen TK, Fröbert O, Graham AN, Endresen PC, Corbascio M, Kajander O, Trivedi U, Hartikainen J, Anttila V, Hildick-Smith D, Thuesen L, Christiansen EH; NOBLE study investigators. Mäkikallio T, et al. Lancet. 2016 Dec 3;388(10061):2743-2752. doi: 10.1016/S0140-6736(16)32052-9. Epub 2016 Oct 31. Lancet. 2016. PMID: 27810312 Clinical Trial.
BACKGROUND: Coronary artery bypass grafting (CABG) is the standard treatment for revascularisation in patients with left main coronary artery disease, but use of percutaneous coronary intervention (PCI) for this indication is incre …
BACKGROUND: Coronary artery bypass grafting (CABG) is the standard treatment for revascularisation in patients with left main …
Fractional flow reserve-guided PCI for stable coronary artery disease.
De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, Jagic N, Mobius-Winckler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd K, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Limacher A, Nüesch E, Jüni P; FAME 2 Trial Investigators. De Bruyne B, et al. N Engl J Med. 2014 Sep 25;371(13):1208-17. doi: 10.1056/NEJMoa1408758. Epub 2014 Sep 1. N Engl J Med. 2014. PMID: 25176289 Free article. Clinical Trial.
BACKGROUND: We hypothesized that in patients with stable coronary artery disease and stenosis, percutaneous coronary intervention (PCI) performed on the basis of the fractional flow reserve (FFR) would be superior to medical therapy. ...Urgent …
BACKGROUND: We hypothesized that in patients with stable coronary artery disease and stenosis, percutaneous coronary
Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study.
Wang HY, Wang Y, Yin D, Gao RL, Yang YJ, Xu B, Dou KF. Wang HY, et al. J Interv Cardiol. 2020 Apr 25;2020:2985435. doi: 10.1155/2020/2985435. eCollection 2020. J Interv Cardiol. 2020. PMID: 32405273 Free PMC article.
BACKGROUND/AIM: The relation between complex percutaneous coronary intervention (PCI), high bleeding risk (HBR), and adverse events after coronary artery implantation of drug-eluting stents has been incompletely characterized. ...More intensifie …
BACKGROUND/AIM: The relation between complex percutaneous coronary intervention (PCI), high bleeding risk (HBR), …
2,960 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page